Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AZN | AMGN | GILD | BMY |
| Company | Alnylam Pharmaceuticals | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 331.61 | 190.46 | 369.99 | 149.69 | 60.00 |
| High | 340.07 | 193.97 | 385.12 | 153.13 | 62.05 |
| Low | 326.51 | 188.49 | 368.90 | 148.71 | 59.77 |
| Latest | 328.16 | 193.03 | 384.32 | 152.50 | 61.99 |
| Change | -3.08 | +5.87 | +16.52 | +3.13 | +2.47 |
| % Change | -0.93% | +3.14% | +4.49% | +2.10% | +4.15% |
| Volume | 1,476,700 | 3,117,624 | 3,839,300 | 8,509,200 | 17,117,286 |
| 20-Day Average Volume | 1,680,755 | 4,836,828 | 3,086,325 | 8,167,130 | 13,480,300 |
| Previous Close | 331.24 | 187.16 | 367.80 | 149.37 | 59.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 356.32 | 187.12 | 343.07 | 134.51 | 55.99 |
| 20-Day Raw Stochastic | 1.99% | 94.08% | 98.78% | 98.14% | 99.29% |
| 20-Day Relative Strength | 31.88 | 58.55 | 71.63 | 76.97 | 73.64 |
| Weighted Alpha | +3.54 | +39.46 | +41.24 | +66.19 | +23.68 |
| Today's Opinion | 72% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 72% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 96% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.93% since 01/30/26 | +4.04% since 01/30/26 | +12.41% since 01/30/26 | +7.43% since 01/30/26 | +12.61% since 01/30/26 |
| Low | 326.51 on 02/06/26 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 140.01 on 02/02/26 | 54.96 on 02/02/26 |
| High | 355.49 on 02/04/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -19.25% since 01/06/26 | +1.64% since 01/06/26 | +16.40% since 01/06/26 | +25.66% since 01/06/26 | +13.91% since 01/06/26 |
| Low | 326.51 on 02/06/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 427.05 on 01/07/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -25.50% since 11/06/25 | +15.21% since 11/06/25 | +21.78% since 11/06/25 | +23.58% since 11/06/25 | +32.94% since 11/06/25 |
| Low | 326.51 on 02/06/26 | 168.44 on 11/07/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 479.79 on 12/03/25 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -23.35% since 08/06/25 | +31.13% since 08/06/25 | +35.01% since 08/06/25 | +38.28% since 08/06/25 | +38.31% since 08/06/25 |
| Low | 326.51 on 02/06/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 495.55 on 10/20/25 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 43,761,436 | 290,267,936 | 198,053,312 | 185,320,384 | 121,168,016 |
| Shares Outstanding, K | 132,114 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 2,248,240,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -278,160,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 1,249,030,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | 251,080,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 0.35 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.90 on 10/30/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/12/26 | 02/10/26 | 05/07/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 1,530.26 | 20.51 | 16.76 | 17.85 | 8.78 |